Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q1 2021 · 10-Q
Revenue$0.00$0.00−100.0% vs Q1 2020 Net Income-$2.22M-$2.22MN/M vs Q1 2020 EPS Diluted-$0.01-$0.01N/M vs Q1 2020 Operating Income-$2,083,574N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 17, 2021 · 47 d after period end